Neurology Letters
Volume & Issue: Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Oral Presentations: Abstracts of the 20th Iranian Multiple Sclerosis Congress
Poster Presentations: Abstracts of the 20th Iranian Multiple Sclerosis Congress
Mind and Art (ORP-01)
Zahra Niknam
MS Prodrome; Is it a fact? (ORP-02)
Farhad Golipoor
A narrative review on the dietary interventions in multiple sclerosis (ORP-03)
Nasim Rezaeimanesh
The importance of vestibular evaluation and rehabilitation in improving the balance in MS patients (ORP-04)
Saeideh Mehrkian
Physical disability assessment: EDSS calculation (ORP-05)
Zahra Ebadi
Horizons of MS therapy: during 30 years (ORP-06)
Seyed Massood Nabavi
Women and Multiple Sclerosis (ORP-07)
Behnaz Sedighi
Clinical Outcome and Volumetric MRI Assessment of Brain and Cervical Spinal Cord Area in Secondary Progressive Multiple Sclerosis Patients Treated with Rituximab: one-year follow-up (ORP-08)
Yousef Mokary; Mohammad Yazdan Panah; Fereshteh Ashtari; Maryam Ahmadi
The role of Artificial Intelligence in cognitive impairment assessment by MRI in people with MS (Iranian Research) (ORP-09)
Vida Niakosari; Sana Hashemi; Ahmad Ali Abin; Maryam Poursadeghfard
Definition and treatment of the multiple sclerosis relapse (ORP-10)
Maryam Poursadeghfard
Patients Monitoring During Treatment With Injectable DMDs (INF and GA) (ORP-11)
Zahra Nikoo
Everything we need to know about vaccination in MS (ORP-12)
Hossein Mozhdehipanah
Typical MRI lesions of multiple sclerosis in the brain and spinal cord (ORP-13)
Zahra Hamed
Advanced imaging for multiple sclerosis (ORP-14)
Elnaz Asadollahzadeh
Diagnostic approach to autoimmune encephalitis (ORP-15)
Hoda Kamali
Femoral head AVN concept and treatments (ORP-16)
Seyyed Hossein Shafiei; Mohammad Soleimani; Alireza Nankali
Brain Stimulation for Cognitive impairment in Multiple Sclerosis (ORP-17)
Mehrdad Roozbeh
MS and cognition: review of clinical, neuro-radiological features, and treatment (ORP-18)
Mahnaz Talebi
Comorbidity in patients with MS (ORP-19)
Fereshteh Ashtari
Review of McDonald criteria (ORP-20)
Atefeh Eidi
Defining seizure type and frequency, and analyzing MRI and EEG findings in MS populations of Khorasan. A cross-sectional study (ORP-21)
Karim Nikkhah; Mahshid Mahyad; H. Abbasi
Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria (ORP-22)
Samaneh Hosseini
Patients monitoring during treatment with Dimethyl fumarate (ORP-23)
Ali Yousefi Pour
Patient monitoring during treatment with natalizumab (ORP-24)
Zohreh Abna
New Technological Approach to Physical Therapy in Patients with Multiple Sclerosis (ORP-25)
Mohammad Hassan Azarsa
EEG Patterns in MS-related epilepsy A literature Review (ORP-26)
Mohammad Reza Najafi
Epidemiological view of national MS registry in Iran (NMSRI) (ORP-27)
Sharareh Eskandarieh
Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy diagnosis and management: A case report study (ORP-28)
Maryam Payere; Mohammad-Ali Nahayati; Soheil Shokri Shakib
Gut-Brain axis and MS: Is this true? (ORP-29)
Morteza Saeidi
Multiple sclerosis and viral hepatitis (ORP-30)
Raika Jamali
Lower urinary tract dysfunction in Multiple Sclerosis, Updates (ORP-31)
Shekoofeh Alaie
Sleep Disturbances and Disease Characteristics of Patients with Multiple Sclerosis in Iran: A Cross-sectional Study (ORP-32)
Mohammad Yazdan Panah; Yousef Mokary; Arshia Ghalamkari; Ahmad Pourmohammadi; Saba Naghavi; Iman Adibi; Fereshteh Ashtari
Effect of eight weeks of respiratory muscle training on respiratory capacity, functional capacity, and quality of life on subjects with mild to moderate relapsing-remitting multiple sclerosis (ORP-33)
Maryam Abolhasani; Shima Ghannadi
Multiple sclerosis and legal medicine (ORP-34)
Mohammadreza Motamed
Optic neuritis and autoimmune optic neuropathies (ORP-35)
Samira Navardi
Treatment approach in Autoimmune encephalitis (ORP-36)
Mohammadali Nahayati
Effect of dynamic neuromuscular stabilization on fatigue and spasticity in people with multiple sclerosis: a randomized controlled trial (ORP-37)
Laleh Abadi Marand
MS Variants (ORP-38)
Ebrahim Kouchaki
Multiple sclerosis, infectious and Gastrointestinal complications (ORP-39)
Hora Heidari
Multiple sclerosis, Pregnancy, Breastfeeding (ORP-40)
Hora Heidari
Patients monitoring during treatment with Teriflunomide (ORP-41)
Nahid Hoseini Nejad Mir
The Role of Advanced MRI Techniques and Artificial Intelligence-based Methods In Diagnosis of Multiple Sclerosis (ORP-42)
Vahid Shahmaei
How to estimate the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis? (ORP-43)
Sepideh Paybast
Update on inflammation, neurodegeneration and immunoregulation in MS (ORP-44)
Mehran Ghaffari
Treatment escalation vs early high efficacy treatment in multiple sclerosis (cons and pros) (ORP-45)
Mohammad Baghbanian
Nutritional recommendations in multiple sclerosis patients: a narrative review (ORP-46)
Nasim Rezaeimanesh
Ophthalmology in multiple sclerosis (ORP-47)
Masoud Aghsaeifard
Paroxysmal Events in Multiple Sclerosis (MS); Pseudoathetosis as a Presenting Symptom of MS (ORP-48)
Ahmad Chitsaz
Patient Monitoring during Treatment with Ocrelizumab and Rituximab (ORP-49)
Nazanin Razazian
Current Updates on the Use of Probiotics as a New Treatment Option for Multiple Sclerosis (ORP-50)
Adrina Habibzadeh; Sara Dehghani; Samin Shiati
Management of seizure in patients with multiple sclerosis (ORP-51)
Ali Akbar Asadi-Pooya
The role of stereotactic biopsy in atypical brain lesions (ORP-52)
Sohrab Shahzadi
Relationship between severity of symptoms of sleep disorders and information processing speed in people with multiple sclerosis (ORP-53)
Saba Naghavi; Fereshteh Ashtari; Aryan Kavosh; Ahmad Pourmohammadi; Iman Adibi; Arshia Ghalamkari; Zahra Karimi
System biology review of multiple sclerosis and discovery of drug targets (ORP-54)
Ali Alizadeh Amiri
Spinal cord MRI in multiple sclerosis; diagnostic, prognostic, and clinical value (ORP-55)
Vahid Shaygannejad
Neuromyelitis Optica Spectrum Disorders (NMOSD); Diagnostic criteria (ORP-56)
Maryam Poursadeghfard
Optic neuritis updates (ORP-57)
Nahid Beladi Moghadam
A middle-aged woman with history of Multiple sclerosis presented with sub-acute encephalopathy (ORP-58)
Sanaz Heydari
Reduction in Circulating Vitamin D Binding Protein in Patients with Multiple sclerosis (ORP-59)
Zhila Maghbooli
Multiple Sclerosis (MS) and Legal Medical Doctrines (ORP-60)
Reza Hajmanouchehri
MS and Environmental Factors (ORP-61)
Mehdi Moghadasi
Care ethics and empathic Practices in dealing with MS Patients (ORP-62)
Hanieh Zaer Rezaei
The effects of crocin on inflammatory biomarkers and mental health in patients with multiple sclerosis: a randomized, double-blinded clinical trial (ORP-63)
Ebrahim Kouchaki; Nasim Safa
A Mechanistic Insight into Sources of Error of Visual Working Memory in Multiple Sclerosis (PP-01)
Ali Motahharynia; Ahmad Pourmohammadi; Armin Adibi; Vahid Shaygannejad; Fereshteh Ashtari; Iman Adibi; Mehdi Sanayei
Acute Brainstem syndrome with NMOSD and related to systemic lupus erythematosus, A Rare Case Report (PP-02)
Mohammad Amin Najafi; Mohammad Amin Reza; Shirin Shams; Ali Rahmati
Acute disseminated encephalomyelitis (ADEM), Report A Rare Case of Refractory form to treatment (PP-03)
Mohammad Amin Najafi
Acute disseminated encephalomyelitis following vaccination against SARS-cov-2: a case report (PP-04)
Ebrahim Pourakbar
Acute Relapses of Neuromyelitis Optica Spectrum Disorder After COVID-19 Vaccination Shot, Among Iranian Patients (PP-05)
Roshanak Mehdipour; Fereshteh Ashtari
Alopecia universalis in a patient under treatment of Ocrelizumab after switching from Rituximab (PP-06)
Mahshid Mahyad; Mohammad Ali Nahayati; Maryam Ebrahimian
Artificial intelligence in multiple sclerosis imaging: advancements, benefits, and challenges (PP-07)
Kimia Kazemzadeh
A Systematic Review and Meta-analysis on Safety and Effectiveness of Extended-interval Dosing of Natalizumab in Patients with Relapsing-remitting Multiple Sclerosis: Is There Any Value in The Cost of Treatment? (PP-08)
Taraneh Mousavi; Behzad Fatemi; Shekoufeh Nikfar; Mohammad Ali Sahraian
Benign Paroxysmal Positioning Vertigo in Multiple Sclerosis (PP-09)
Fatemeh Jafarlou
Cardiovascular autonomic dysfunction in MS (PP-10)
Ashraf Zarvani; Nasim Tabrizi
Case presentation, Atypical imaging of MS (PP-11)
Gholamali Yousefipour
Comparing the Impact of Bariatric Surgery and Diet Therapy on MS Disease-Related Symptoms: A Systematic Review Study (PP-12)
Neda Ramezani; Elahe Ahmadikhonsaraki; Atoosa Khosravi; Alireza Taghdisi Kashani; Azam Eshaghian-Dorcheh; Zahra Karimi; Saba Naghavi; Ghazal Zandieh; Ahmad Pourmohammadi; Amirhossein Davarpanah Jazi; Iman Adibi
Demyelinating Disease Following Anti-TNFa Treatment (Adalimumab) in Patients with psoriasis: A Case Report (PP-13)
Mohammadreza Malek Zadeh
Demyelinating etiology as a possible cause of Parry–Romberg Syndrome (PP-14)
K. Bahrami; Mohammad Ali Nahayati; Mohammad Shriati
Diagnosis of multiple sclerosis and Fahr's Disease in a young woman: A case report (PP-15)
Mohammadreza Malek Zadeh; Pourandokht Mousavian; Mohammad Ali Nahayati
Early Clinical Response and Complications of Therapeutic Plasma Exchange in Central Nervous System Demyelinating Diseases (PP-16)
Mehran Rashidi Alavijeh; Saba Naghavi; Neda Ramazani; Sayed Mohsen Hosseini; Iman Adibi
The Effect of Multiple Sclerosis on Peripheral Audio-Vestibular System (PP-17)
Fatemeh Jafarlou
Long-term and Short-term Episodic Memory Dysfunction in Female MS Patients (PP-18)
Sara Yazdani; Mohsen Foroughipour
Headache first manifestation of Multiple Sclerosis (PP-19)
Fatemeh Abrishamchi
Investigating the relationship between stress, anxiety and depression with the quality (PP-20)
Majid Jafari; Masoud Lotfizadeh; Razieh Hashemi
Is There a Need to Differentiate Atypical Multiple Sclerosis from Neuromyelitis Optica Spectrum Disorders (NMOSD)? The Pros and Cons: A Systematic Review (PP-21)
Sepideh Paybast; Fatemeh Baghalha; Ali Emami; Abdorreza Naser Moghadasi
Lingual dystonia as the first manifestation of multiple sclerosis (PP-22)
Farid Shamlou
MS and exercise (PP-23)
Maryam Abolhasani; Farzin Halabchi
Multidisciplinary rehabilitative management (PP-24)
Razieh Pirzad
Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review (PP-25)
Fardin Nabizadeh; Elham Ramezannezhad; Kimia Kazemzadeh; Elham Khalili; Elham Moases Ghaffary; Omid Mirmosayyeb
Neurosarcoidosis in an adult man with a family history of MS: A Case report (PP-26)
Elham Sadat Azimi
Patterns of Attention Deficit in Relapsing and Progressive Phenotypes of Multiple Sclerosis (PP-27)
Farinaz Tabibian; Kiarash Azimzadeh; Vahid Shaygannejad; Fereshteh Ashtari; Iman Adibi; Mehdi Sanayei
Personality traits of patients with multiple sclerosis and their correlation with anxiety and depression levels: A cross-sectional case-control study (PP-28)
Amir Ali Gharemani
Comparison of COVID-19 infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination Between Patients with Multiple Sclerosis and Other Neurological Disorders (PP-29)
Mohammad Yazdan Panah; Saeed Vaheb; Yousef Mokary; Elham Moases Ghaffary; Alireza Afshari-Safavi; Aysa Shaygannejad; Narges Ebrahimi; Vahid Shaygannejad; Omid Mirmosayyeb
Pharmacogenomics of Multiple Sclerosis: Sieving treatment biomarkers from blood gene-expression profiles (PP-30)
Maryam Mohaghegh; Mohammad Hossein Sanati; Mitra Ataei; Mehdi Sadeghi; Shokoufeh Alayi
)